These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32024766)

  • 1. Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems.
    Rehbach K; Fernando MB; Brennand KJ
    J Neurosci; 2020 Feb; 40(6):1176-1185. PubMed ID: 32024766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.
    Matos MR; Ho SM; Schrode N; Brennand KJ
    Mol Cell Neurosci; 2020 Sep; 107():103532. PubMed ID: 32712198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Genome Mapping Reveals Genomic Alterations upon Gene Editing in hiPSCs: Implications for Neural Tissue Differentiation and Brain Organoid Research.
    Gallego Villarejo L; Gerding WM; Bachmann L; Hardt LHI; Bormann S; Nguyen HP; Müller T
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids.
    Tian A; Muffat J; Li Y
    J Neurosci; 2020 Feb; 40(6):1186-1193. PubMed ID: 32024767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
    Alagoz M; Kherad N
    Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
    Garreta E; González F; Montserrat N
    Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR editing in biological and biomedical investigation.
    Huang J; Wang Y; Zhao J
    J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
    Horii T; Hatada I
    Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
    Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
    Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells.
    LaMarca EA; Powell SK; Akbarian S; Brennand KJ
    Front Pediatr; 2018; 6():82. PubMed ID: 29666786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of kidney organoids derived from human pluripotent stem cells.
    Kim YK; Nam SA; Yang CW
    Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis.
    Sun YH; Kao HKJ; Chang CW; Merleev A; Overton JL; Pretto D; Yechikov S; Maverakis E; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2020 Jan; 38(1):90-101. PubMed ID: 31566285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.